---
document_datetime: 2025-10-07 16:09:41
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/bemrist-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: bemrist-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 7.1168135
conversion_datetime: 2025-12-19 02:39:05.859987
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Bemrist Breezhaler

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,youmayneed to alsorefer toEPAR-Procedural steps taken and scientific information after authorisation (archive).

| Applicationnumber   | Scope                       | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amended on   | Product Information affected3   | Summary   |
|---------------------|-----------------------------|-------------------------------------|-------------------------------------------|---------------------------------|-----------|
| Variation type IA / | A.ADMINISTRATIVECHANGES-A.7 | 07/10/2025                          |                                           | Annex II and                    |           |

1Notifications areissuedfortypeIvariations andArticle61(3)notifications(unlesspartofagroupincludinga typeIIvariationorextensionapplicationoraworksharingapplication).Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),Annex II,Labelling,PL(PackageLeaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g. summary of product characteristics, annex II, labelling,package leaflet).The CDisissuedwithintwomonthsof theopinionforvariationsfallingunderthescopeofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000303707   | Deletion ofmanufacturing sitesforan active substance,intermediate or finished product, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place,orsupplierofastartingmaterial, reagentorexcipient(whenmentioned in the dossier)*-Accepted                                                                                          |            |     | PL   |                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|-------------------|
| Variation typeIA/   | A.ADMINISTRATIVE CHANGES-A.7 Deletion ofmanufacturing sitesforan active substance, intermediate or finished product, packaging site,manufacturerresponsiblefor batchrelease,sitewherebatchcontroltakes place,or supplier of a startingmaterial, reagent or excipient (when mentioned in the dossier)*-Accepted                                                       | 31/07/2025 | N/A |      | EMA/VR/0000244278 |
|                     | A.ADMINISTRATIVECHANGES-A.7 Deletionofmanufacturingsitesforanactive substance,intermediate orfinishedproduct, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place,orsupplierofastartingmaterial, reagentorexcipient(whenmentioned in the dossier)* - Accepted A.ADMINISTRATIVECHANGES-A.4Change in thename and/or addressof:a |            |     |      |                   |
|                     | manufacturer (including where relevant quality control testing sites);or anASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate                                                                                                                                                                                                |            |     |      |                   |

<div style=\"page-break-after: always\"></div>

| usedinthemanufactureof the active dossier)where noPh.Eur.Certificate of substance orstarting manufacturingprocess of the active approved testprocedure-Accepted B.III.1.bEuropeanPharmacopoeial TSE   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| substance(where specified in thetechnical                                                                                                                                                             |
| Suitability is part of the approved dossier; or                                                                                                                                                       |
| a manufacturer of a novel excipient (where                                                                                                                                                            |
| specified in the technical dossier)-Accepted                                                                                                                                                          |
| B.1.b.2 Change in test procedurefor active                                                                                                                                                            |
| material/reagent/intermediate used in the                                                                                                                                                             |
| substance-B.I.b.2.a Minor changes to an                                                                                                                                                               |
| Certificate ofsuitabilityfor an active                                                                                                                                                                |
| substance/startingmaterial/reagent/                                                                                                                                                                   |
| intermediate/or excipient-B.III.1.b.4                                                                                                                                                                 |
| Deletionof certificates(incase multiple                                                                                                                                                               |
| certificates exist per material) - Accepted                                                                                                                                                           |
| B.III.1.bEuropeanPharmacopoeial TSE                                                                                                                                                                   |
| Certificate ofsuitabilityfor anactive                                                                                                                                                                 |
| substance/startingmaterial/reagent/                                                                                                                                                                   |
| intermediate/orexcipient-B.Ill.1.b.2New                                                                                                                                                               |
| certificate for a starting material/reagent/                                                                                                                                                          |
| intermediate/orexcipientfromaneworan                                                                                                                                                                  |
| alreadyapprovedmanufacturer-Accepted                                                                                                                                                                  |
| B.III.1.bEuropeanPharmacopoeial TSE                                                                                                                                                                   |
| Certificate ofsuitabilityfor anactive                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| intermediate/or excipient - B.II1.1.b.2 New certificate for a starting material/reagent/ intermediate/or excipient from a new or an already approved manufacturer- Accepted   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|